Welcome to our dedicated page for Phibro Animal Health news (Ticker: PAHC), a resource for investors and traders seeking the latest updates and insights on Phibro Animal Health stock.
Phibro Animal Health Corporation reports developments in animal health, mineral nutrition and performance products for food-animal markets. The company develops, manufactures and markets antibacterials, anticoccidials, nutritional specialty products, vaccines and mineral nutrition products for poultry, swine, beef and dairy cattle, and aquaculture in the United States and international markets.
Recurring PAHC news includes quarterly results and guidance, cash dividend declarations on Class A and Class B common stock, investor conference participation and regulatory updates affecting antimicrobial products such as virginiamycin and bacitracin. Company updates also address product portfolio activity, acquisition-related effects, input and distribution costs, foreign-currency impacts and tools such as PhibroVet for veterinary prescription management.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Phibro Animal Health Corporation (NASDAQ: PAHC) is set to announce its third quarter financial results on May 3, 2023, after market close. A conference call will follow on May 4, 2023, at 9:00 AM ET, accessible via phone or webcast. Interested parties can find the webcast on the company's investor relations page. Phibro aims to provide solutions for animal health and nutrition, enhancing the well-being of livestock and companion animals. More details about the results will be made available during the call, along with insights into the company's performance and future outlook.
Phibro Animal Health Corporation (NASDAQ: PAHC) will participate in the Bank of America Securities 2023 Health Care Conference on May 9, 2023, at 4:20 PM PDT. Chief Financial Officer Damian Finio will present to financial analysts and investors. The live audio presentation can be accessed on the company’s Investor Relations website, with a replay and archived session available thereafter.
Phibro is a global leader in animal health and mineral nutrition, dedicated to supporting livestock producers, veterinarians, and consumers in enhancing animal health. For more information, visit www.pahc.com.
Phibro Animal Health Corporation (NASDAQ: PAHC) will participate in the Barclays Global Healthcare Conference on March 15, 2023, at 10:45 AM ET. CFO Damian Finio will present to financial analysts and investors at the Loews Miami Beach Hotel. A live audio presentation will be available on the company's Investor Relations Website, with a replay to follow. Phibro is recognized as a leader in animal health and mineral nutrition, supporting livestock producers and veterinarians in enhancing animal wellbeing.